We found complete eradication of tumours with more than 1‐year survival in 50% of the mice treated with RGD4C.TPA.IL15IgK, indicating a curative response, while all mice receiving the non‐targeted particle died 50 days after initial TPA administration (Fig 6E). This evidence concerns the gene PLAT and neoplasm.